PubMed:9315663
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 72-99 | protein | denotes | retinoblastoma gene product |
| T2 | 103-121 | cell_line | denotes | promonocytic cells |
| T3 | 148-175 | protein | denotes | retinoblastoma gene product |
| T4 | 177-180 | protein | denotes | pRB |
| T5 | 324-327 | protein | denotes | pRB |
| T6 | 390-393 | protein | denotes | tTG |
| T7 | 561-564 | protein | denotes | pRB |
| T8 | 597-607 | cell_line | denotes | U937 cells |
| T9 | 688-698 | cell_line | denotes | U937 cells |
| T10 | 787-790 | protein | denotes | pRB |
| T11 | 931-934 | protein | denotes | pRB |
| T12 | 1033-1043 | cell_line | denotes | U937 cells |
| T13 | 1128-1131 | protein | denotes | pRB |
| T14 | 1216-1221 | protein | denotes | E2F-1 |
| T15 | 1265-1280 | cell_line | denotes | pRB-null clones |
| T16 | 1286-1296 | cell_line | denotes | U937 cells |
| T17 | 1319-1322 | protein | denotes | pRB |
| T18 | 1332-1351 | cell_line | denotes | U937-derived clones |
| T19 | 1366-1380 | cell_line | denotes | p53-null cells |
| T20 | 1508-1511 | protein | denotes | tTG |
| T21 | 1527-1538 | protein | denotes | pRB protein |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-143 | Sentence | denotes | Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. |
| S2 | 144-271 | Sentence | denotes | The retinoblastoma gene product (pRB) plays an important role in controlling both cell release from the G1 phase and apoptosis. |
| S3 | 272-414 | Sentence | denotes | We show here that in the early phases of apoptosis, pRB is posttranslationally modified by a tissue transglutaminase (tTG)-catalyzed reaction. |
| S4 | 415-629 | Sentence | denotes | In fact, by employing a novel haptenized lysis synthetic substrate which allows the isolation of glutaminyl-tTG substrates in vivo, we identified pRB as a potential tTG substrate in U937 cells undergoing apoptosis. |
| S5 | 630-917 | Sentence | denotes | In keeping with this finding, we showed that apoptosis of U937 cells is characterized by the rapid disappearance of the 105,000- to 110,000-molecular-weight pRB forms concomitantly with the appearance of a smear of immunoreactive products with a molecular weight of greater than 250,000. |
| S6 | 918-1109 | Sentence | denotes | The shift in pRB molecular weight was reproduced by adding exogenous purified tTG to extracts obtained from viable U937 cells and was prevented by dansylcadaverine, a potent enzyme inhibitor. |
| S7 | 1110-1297 | Sentence | denotes | The effect of the pRB posttranslational modification during apoptosis was investigated by determining the E2F-1 levels and by isolating and characterizing pRB-null clones from U937 cells. |
| S8 | 1298-1467 | Sentence | denotes | Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide. |
| S9 | 1468-1619 | Sentence | denotes | Taken together, these data suggest that tTG, acting on the pRB protein, might play an important role in the cell progression through the death program. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 68-99 | NP | denotes | the retinoblastoma gene product |
| C2 | 133-142 | NP | denotes | apoptosis |
| C3 | 144-181 | NP | denotes | The retinoblastoma gene product (pRB) |
| C4 | 261-270 | NP | denotes | apoptosis |
| C5 | 313-322 | NP | denotes | apoptosis |
| C6 | 324-327 | NP | denotes | pRB |
| C7 | 437-481 | NP | denotes | a novel haptenized lysis synthetic substrate |
| C8 | 482-487 | NP | denotes | which |
| C9 | 561-564 | NP | denotes | pRB |
| C10 | 619-628 | NP | denotes | apoptosis |
| C11 | 688-698 | NP | denotes | U937 cells |
| C12 | 1065-1081 | NP | denotes | dansylcadaverine |
| C13 | 1083-1108 | NP | denotes | a potent enzyme inhibitor |
| C14 | 1170-1179 | NP | denotes | apoptosis |
| C15 | 1265-1280 | NP | denotes | pRB-null clones |
| C16 | 1286-1296 | NP | denotes | U937 cells |
| C17 | 1319-1322 | NP | denotes | pRB |
| C18 | 1326-1351 | NP | denotes | these U937-derived clones |
| C19 | 1360-1380 | NP | denotes | these p53-null cells |
| C20 | 1523-1538 | NP | denotes | the pRB protein |
| C21 | 1601-1618 | NP | denotes | the death program |
| R1 | C3 | C1 | coref-ident | The retinoblastoma gene product (pRB),the retinoblastoma gene product |
| R2 | C4 | C2 | coref-ident | apoptosis,apoptosis |
| R3 | C5 | C4 | coref-ident | apoptosis,apoptosis |
| R4 | C6 | C3 | coref-ident | pRB,The retinoblastoma gene product (pRB) |
| R5 | C8 | C7 | coref-relat | which,a novel haptenized lysis synthetic substrate |
| R6 | C9 | C6 | coref-ident | pRB,pRB |
| R7 | C10 | C5 | coref-ident | apoptosis,apoptosis |
| R8 | C13 | C12 | coref-appos | a potent enzyme inhibitor,dansylcadaverine |
| R9 | C14 | C10 | coref-ident | apoptosis,apoptosis |
| R10 | C16 | C11 | coref-ident | U937 cells,U937 cells |
| R11 | C17 | C9 | coref-ident | pRB,pRB |
| R12 | C18 | C15 | coref-ident | these U937-derived clones,pRB-null clones |
| R13 | C19 | C18 | coref-ident | these p53-null cells,these U937-derived clones |
| R14 | C20 | C17 | coref-ident | the pRB protein,pRB |
| R15 | C21 | C14 | coref-ident | the death program,apoptosis |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-64 | other_name | denotes | Tissue transglutaminase-dependent posttranslational modification |
| T2 | 72-99 | protein_molecule | denotes | retinoblastoma gene product |
| T3 | 103-121 | cell_line | denotes | promonocytic cells |
| T4 | 133-142 | other_name | denotes | apoptosis |
| T5 | 148-175 | protein_molecule | denotes | retinoblastoma gene product |
| T6 | 177-180 | protein_molecule | denotes | pRB |
| T7 | 226-238 | other_name | denotes | cell release |
| T8 | 248-256 | other_name | denotes | G1 phase |
| T9 | 261-270 | other_name | denotes | apoptosis |
| T10 | 313-322 | other_name | denotes | apoptosis |
| T11 | 324-327 | protein_molecule | denotes | pRB |
| T12 | 365-390 | other_name | denotes | tissue transglutaminase ( |
| T13 | 390-393 | protein_molecule | denotes | tTG |
| T14 | 439-481 | other_organic_compound | denotes | novel haptenized lysis synthetic substrate |
| T15 | 512-537 | other_organic_compound | denotes | glutaminyl-tTG substrates |
| T16 | 561-564 | protein_molecule | denotes | pRB |
| T17 | 570-593 | other_organic_compound | denotes | potential tTG substrate |
| T18 | 597-607 | cell_line | denotes | U937 cells |
| T19 | 619-628 | other_name | denotes | apoptosis |
| T20 | 675-684 | other_name | denotes | apoptosis |
| T21 | 688-698 | cell_line | denotes | U937 cells |
| T22 | 787-790 | protein_molecule | denotes | pRB |
| T23 | 931-934 | protein_molecule | denotes | pRB |
| T24 | 977-999 | other_organic_compound | denotes | exogenous purified tTG |
| T25 | 1033-1043 | cell_line | denotes | U937 cells |
| T26 | 1065-1081 | other_organic_compound | denotes | dansylcadaverine |
| T27 | 1085-1108 | other_organic_compound | denotes | potent enzyme inhibitor |
| T28 | 1128-1131 | protein_molecule | denotes | pRB |
| T29 | 1170-1179 | other_name | denotes | apoptosis |
| T30 | 1216-1221 | protein_molecule | denotes | E2F-1 |
| T31 | 1265-1268 | protein_molecule | denotes | pRB |
| T32 | 1286-1296 | cell_line | denotes | U937 cells |
| T33 | 1319-1322 | protein_molecule | denotes | pRB |
| T34 | 1332-1351 | cell_line | denotes | U937-derived clones |
| T35 | 1366-1380 | cell_line | denotes | p53-null cells |
| T36 | 1401-1410 | other_name | denotes | apoptosis |
| T37 | 1422-1438 | other_name | denotes | serum withdrawal |
| T38 | 1440-1452 | other_organic_compound | denotes | calphostin C |
| T39 | 1458-1466 | other_organic_compound | denotes | ceramide |
| T40 | 1508-1511 | protein_molecule | denotes | tTG |
| T41 | 1527-1530 | protein_molecule | denotes | pRB |